Works matching DE "MONOCLONAL antibodies"

Results: 5000

Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?

Published in:

OncoImmunology, 2015, v. 4, n. 7, p. N.PAG, doi. 10.1080/2162402X.2015.1058597

By:

Kroemer, Guido;
Galluzzi, Lorenzo;
Zitvogel, Laurence;
Fridman, Wolf Hervé

Publication type:

Article

Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma.

Published in:

OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008853

By:

Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.

Published in:

OncoImmunology, 2015, v. 4, n. 4, p. 00, doi. 10.1080/2162402X.2015.1008814

By:

Eggermont, Alexander;
Marabelle, Aurélien;
Zitvogel, Laurence;
Buqué, Aitziber;
Galluzzi, Lorenzo;
Bloy, Norma;
Castoldi, Francesca;
Tartour, Eric;
Kroemer, Guido;
Cremer, Isabelle;
Galon, Jérôme;
Fridman, Wolf Hervé;
Aranda, Fernando;
Spisek, Radek;
Fucikova, Jitka

Publication type:

Article

Neutralization of membrane complement regulators improves complement-dependent effector functions of therapeutic anticancer antibodies targeting leukemic cells.

Published in:

OncoImmunology, 2015, v. 4, n. 3, p. 00, doi. 10.4161/2162402X.2014.979688

By:

Mamidi, Srinivas;
Höne, Simon;
Teufel, Claudia;
Sellner, Leopold;
Zenz, Thorsten;
Kirschfink, Michael

Publication type:

Article

Novel immune checkpoint blocker approved for the treatment of advanced melanoma.

Published in:

2014

By:

Galluzzi, Lorenzo;
Kroemer, Guido;
Eggermont, Alexander

Publication type:

Editorial

Recent advances and new opportunities for targeting human dendritic cells in situ.

Published in:

OncoImmunology, 2014, v. 3, n. 8, p. N.PAG, doi. 10.4161/21624011.2014.954832

By:

Dhodapkar, Madhav V;
Dhodapkar, Kavita M

Publication type:

Article

Late development of splenic sarcoidosis-like lesions in a patient with metastatic melanoma and long-lasting clinical response to ipilimumab.

Published in:

OncoImmunology, 2014, v. 3, n. 8, p. N.PAG, doi. 10.4161/21624011.2014.954506

By:

Andersen, Rikke;
Nørgaard, Peter;
Al-Jailawi, Mohamad Kadhem Mohamad;
Svane, Inge Marie

Publication type:

Article

CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies.

Published in:

OncoImmunology, 2014, v. 3, n. 7, p. N.PAG, doi. 10.4161/21624011.2014.941740

By:

Houot, Roch;
Kohrt, Holbrook

Publication type:

Article

Macrophages in the liver prevent metastasis by efficiently eliminating circulating tumor cells after monoclonal antibody immunotherapy.

Published in:

OncoImmunology, 2014, v. 3, n. 4, p. N.PAG, doi. 10.4161/onci.28441

By:

Gül, Nuray;
Babes, Liane;
Kubes, Paul;
van Egmond, Marjolein

Publication type:

Article

Immune checkpoints.

Published in:

OncoImmunology, 2014, v. 3, n. 4, p. N.PAG, doi. 10.4161/onci.28325

By:

Chawla, Akhil;
Philips, Anne V;
Alatrash, Gheath;
Mittendorf, Elizabeth

Publication type:

Article

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo.

Published in:

OncoImmunology, 2014, v. 3, n. 1, p. N.PAG, doi. 10.4161/onci.27614

By:

Sandin, Linda C;
Eriksson, Fredrik;
Ellmark, Peter;
Loskog, Angelica SI;
Tötterman, Thomas H;
Mangsbo, Sara M

Publication type:

Article

Inhibiting the inhibitors: Checkpoints blockade in solid tumors.

Published in:

2013

By:

Mavilio, Domenico;
Lugli, Enrico

Publication type:

Editorial

A role for CCL2 in both tumor progression and immunosurveillance.

Published in:

OncoImmunology, 2013, v. 2, n. 7, p. e25474-1, doi. 10.4161/onci.25474

By:

Ming Li;
Knight, Deborah A.;
Snyder, Linda A.;
Smyth, Mark J.;
Stewart, Trina J.

Publication type:

Article

Strategies for purging CD96+ stem cells in vitro and in vivo.

Published in:

OncoImmunology, 2013, v. 2, n. 6, p. e24500-1, doi. 10.4161/onci.24500

By:

Staudinger, Matthias;
Humpe, Andreas;
Gramatzki, Martin

Publication type:

Article

EGFR expression levels affect the mode of action of EGFR-targeting monoclonal antibodies.

Published in:

OncoImmunology, 2013, v. 2, n. 5, p. e24052-1, doi. 10.4161/onci.24052

By:

Derer, Stefanie;
Lohse, Stefan;
Valerius, Thomas

Publication type:

Article

Trial watch Monoclonal antibodies in cancer therapy.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e22789-1, doi. 10.4161/onci.22789

By:

Vacchelli, Erika;
Eggermont, Alexander;
Galon, Jérôme;
Sautès-Fridman, Catherine;
Zitvogel, Laurence;
Kroemer, Guido;
Galluzzi, Lorenzo

Publication type:

Article

Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors.

Published in:

OncoImmunology, 2013, v. 2, n. 1, p. e23033-1, doi. 10.4161/onci.23033

By:

Vonderheide, Robert H.;
Burg, Jennifer M.;
Mick, Rosemarie;
Trosko, Jennifer A.;
Dongguang Li;
Naveed Shaik, M.;
Tolcher, Anthony W.;
Hamid, Omid

Publication type:

Article

Virotherapy, gene transfer and immunostimulatory monoclonal antibodies.

Published in:

OncoImmunology, 2012, v. 1, n. 8, p. 1345, doi. 10.4161/onco.21679

By:

Quetglas, José I.;
John, Liza B.;
Kershaw, Michael H.;
Álvarez-Vallina, Luis;
Melero, Ignacio;
Darcy, Phillip K.;
Smerdou, Cristian

Publication type:

Article

The serum level of NX-DCP-R, but not DCP, is not increased in alcoholic liver disease without hepatocellular carcinoma.

Published in:

Cancer Biomarkers, 2016, v. 16, n. 1, p. 171, doi. 10.3233/CBM-150553

By:

Masaya Saito;
Yoshihiko Yano;
Hirotaka Hirano;
Kenji Momose;
Kentaro Mouri;
Akitoyo Hishimoto;
Masaru Yoshida;
Takeshi Azuma

Publication type:

Article

LNA-based PCR clamping enrichment assay for the identification of KRAS mutations.

Published in:

Cancer Biomarkers, 2011, v. 8, n. 2, p. 89, doi. 10.3233/CBM-2011-0203

By:

Efrati, Edna;
Elkin, Hela;
Peerless, Yehudit;
Sabo, Edmond;
Ben-Izhak, Ofer;
Hershkovitz, Dov

Publication type:

Article

Developing recombinant antibodies for biomarker detection.

Published in:

Cancer Biomarkers, 2010, v. 6, n. 5/6, p. 271, doi. 10.3233/CBM-2009-0144

By:

Baird, Cheryl L.;
Fischer, Christopher J.;
Pefaur, Noah B.;
Miller, Keith D.;
Kagan, Jacob;
Srivastava, Sudhir;
Rodland, Karin D.

Publication type:

Article

Cancer cell expressions of immunoglobulin heavy chains with unique carbohydrate-associated biomarker.

Published in:

Cancer Biomarkers, 2009, v. 5, n. 4/5, p. 177, doi. 10.3233/CBM-2009-0102

By:

Lee, Gregory;
Ge, Bixia

Publication type:

Article

Cancer cell-expressed immunoglobulins: CA215 as a pan cancer marker and its diagnostic applications.

Published in:

Cancer Biomarkers, 2009, v. 5, n. 3, p. 137, doi. 10.3233/CBM-2009-0610

By:

Lee, Gregory

Publication type:

Article

Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.

Published in:

2023

By:

Zhang, Peiheng;
Yu, Yang;
Gao, Ying;
Yuan, Geheng;
Zhang, Junqing;
Wang, Wei

Publication type:

Case Study

Trial Watch: Immunostimulatory cytokines.

Published in:

OncoImmunology, 2012, v. 1, n. 4, p. 493, doi. 10.4161/onci.20459

By:

Vacchelli, Erika;
Galluzzi, Lorenzo;
Eggermont, Alexander;
Galon, Jerome;
Tartour, Eric;
Zitvogel, Laurence;
Kroemer, Guido

Publication type:

Article

Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo.

Published in:

OncoImmunology, 2012, v. 1, n. 4, p. 477, doi. 10.4161/onci.19864

By:

Cheung, Nai-Kong V.;
Hongfen Guo;
Jian Hu;
Tassev, Dimiter V.;
Cheung, Irene Y.

Publication type:

Article

CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection.

Published in:

OncoImmunology, 2012, v. 1, n. 4, p. 544, doi. 10.4161/onci.19442

By:

Waitz, Rebecca;
Fassò, Marcella;
Allison, James P.

Publication type:

Article

Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson's Disease Research.

Published in:

Journal of Parkinson's Disease, 2024, v. 14, n. 1, p. 65, doi. 10.3233/JPD-230295

By:

Jong, Tiffany;
Gehrlein, Alexandra;
Sidransky, Ellen;
Jagasia, Ravi;
Chen, Yu

Publication type:

Article

Monoclonal Antibodies in Neurodegenerative Disease May Work, But They Don't Help: A Perspective from Physicians.

Published in:

Journal of Parkinson's Disease, 2022, v. 12, n. 8, p. 2289, doi. 10.3233/JPD-225032

By:

Richard, Edo;
Bloem, Bastiaan R.

Publication type:

Article

RSV hospitalizations for youngest babies cut in half after immunizations become available.

Published in:

Neonatology Today, 2025, v. 20, n. 5, p. 159

By:

Jenco, Melissa

Publication type:

Article

Coupling high‐throughput and modeling approaches to streamline early‐stage process development for biologics.

Published in:

Biotechnology Progress, 2025, v. 41, n. 3, p. 1, doi. 10.1002/btpr.3523

By:

Welsh, John P.;
Altern, Scott H.;
Lyall, Jessica Y.;
Burgess, Sean;
Rauscher, Michael A.;
Lenhoff, Abraham M.;
Cramer, Steven M.;
Williams, Chris

Publication type:

Article

Patients' Global Impression of Change (PGIC) Score Compared to Monthly Migraine Days to Evaluate Treatment Persistence With Anti‐CGRP Monoclonal Antibodies.

Published in:

Annals of Clinical & Translational Neurology, 2025, v. 12, n. 6, p. 1292, doi. 10.1002/acn3.70053

By:

Romozzi, Marina;
Vollono, Catello;
Calabresi, Paolo;
De Cesaris, Francesco;
Iannone, Luigi Francesco

Publication type:

Article

3-year data show positive vision, fluid status maintenance for faricimab in wet AMD.

Published in:: Ocular Surgery News, 2025, v. 43, n. 11, p. 1
Publication type:: Article

Rapid response to ixekizumab in a patient with erythrodermic psoriasis and drug-induced cirrhosis.

Published in:

2025

By:

Ran, Delin;
Wang, Na;
Liu, Jing;
Qu, Peng;
Yang, Baoqi

Publication type:

Letter

Classical and biological treatments in mycosis fungoides/Sézary syndrome. New horizons in oncodermatology.

Published in:

Advances in Dermatology & Allergology / Postępy Dermatologii i Alergologii, 2025, v. 42, n. 2, p. 125, doi. 10.5114/ada.2024.144999

By:

Cisoń, Hanna R.;
Białynicki-Birula, Rafał K.

Publication type:

Article

Cosibelimab.

Published in:: American Journal of Health-System Pharmacy, 2025, v. 82, n. 12, p. 638, doi. 10.1093/ajhp/zxaf055
Publication type:: Article

Correction: The Evolution of Anti‑CD20 Treatment for Multiple Sclerosis: Optimization of Antibody Characteristics and Function.

Published in:

2025

By:

Cree, Bruce A. C.;
Berger, Joseph R.;
Greenberg, Benjamin

Publication type:

Correction Notice

Theranostics using 89Zr/177Lu-labeled antibody targeting erythropoietin-producing hepatocellular A2 (EphA2).

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 8, p. 2887, doi. 10.1007/s00259-025-07139-9

By:

Watabe, Tadashi;
Iwasawa, Takumi;
Kimura, Hiroyuki;
Shirakami, Yoshifumi;
Naka, Sadahiro;
Kaneda, Kazuko;
Kobayashi, Takanori;
Omokawa, Marina;
Yagi, Yusuke;
Tomiyama, Noriyuki;
Kato, Kazunori

Publication type:

Article

A Novel c.459_460insC Variation in the XK Gene Associated with McLeod Syndrome.

Published in:

Transfusion Medicine & Hemotherapy, 2025, v. 52, n. 3, p. 211, doi. 10.1159/000539875

By:

Zhang, Bing;
Yu, Shifang;
Hong, Xiaozhen;
Xu, Xianguo;
Zhu, Faming

Publication type:

Article

The use of Bevacizumab in the treatment of brain arteriovenous malformations: a systematic review.

Published in:

Neurosurgical Review, 2025, v. 48, n. 1, p. 1, doi. 10.1007/s10143-025-03667-y

By:

Baig Mirza, Asfand;
Fayez, Feras;
Al-Munaer, Marwan;
Georgiannakis, Ariadni;
Burn, Layla;
Ravi, Karthik;
Vastani, Amisha;
Syrris, Christoforos;
Patel, Jash;
Matloob, Samir

Publication type:

Article

Respiratory syncytial virus preventives for children in Australia: current landscape and future directions.

Published in:

Medical Journal of Australia, 2025, v. 222, n. 11, p. 579, doi. 10.5694/mja2.52671

By:

Barnett, Sam T;
Tuckerman, Jane;
Barr, Ian G;
Crawford, Nigel W;
Wurzel, Danielle F

Publication type:

Article

Nirsevimab immunisation of infants and respiratory syncytial virus (RSV)‐associated hospitalisations, Western Australia, 2024: a population‐based analysis.

Published in:

Medical Journal of Australia, 2025, v. 222, n. 11, p. 568, doi. 10.5694/mja2.52655

By:

Bloomfield, Lauren E;
Pingault, Nevada V;
Foong, Rachel E;
French, Sarah;
Morgan, Jo‐Anne;
Wadia, Ushma;
Moore, Hannah C;
Blyth, Christopher C;
Richmond, Peter C;
Armstrong, Paul K;
Effler, Paul V

Publication type:

Article

Ocular Toxicity in GD-2 Antibody Therapy: A Case Study.

Published in:

Journal of Pediatric Hematology/Oncology Nursing, 2025, v. 42, n. 1/2, p. 51, doi. 10.1177/27527530251318685

By:

Fraser, Brooke

Publication type:

Article

Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy Open Access.

Published in:

QJM: An International Journal of Medicine, 2025, v. 118, n. 4, p. 306, doi. 10.1093/qjmed/hcaf026

By:

Kashio, Takeshi;
Horino, Taro;
Yagyu, Kenichi;
Osakabe, Yuki;
Inotani, Satoshi;
Terada, Yoshio

Publication type:

Article

Short- and long-term effects of early versus delayed treatment with ocrelizumab on cerebellar volume loss in patients with RMS and PPMS.

Published in:

Multiple Sclerosis Journal, 2025, v. 31, n. 7, p. 821, doi. 10.1177/13524585251325086

By:

Arnold, Douglas L;
Kolind, Shannon;
Assemlal, Haz-Edine;
Bar-Or, Amit;
Inglese, Matilde;
Kappos, Ludwig;
Parmar, Katrin;
Sprenger, Till;
Traboulsee, Anthony;
Vavasour, Irene M;
Wolinsky, Jerry S;
Bernasconi, Corrado;
Bonati, Ulrike;
Magon, Stefano;
Tackenberg, Björn;
Gaetano, Laura

Publication type:

Article

Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study Open Access.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2731, doi. 10.1093/rheumatology/keae647

By:

Anders, Hans-Joachim;
Chan, Tak Mao;
Sanchez-Guerrero, Jorge;
Wofsy, David;
Bensley, Karen;
Kim, Lilianne;
Lo, Kim Hung;
Shu, Cathye;
Shao, Jie;
Karyekar, Chetan S;
Diamond, Betty

Publication type:

Article

Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS Open Access.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2565, doi. 10.1093/rheumatology/keae586

By:

Gossec, Laure;
Baraliakos, Xenofon;
Aletaha, Daniel;
Sharaf, Mohamed;
Rampakakis, Emmanouil;
Lavie, Frédéric;
López-Medina, Clementina;
Selmi, Carlo;
Coates, Laura C

Publication type:

Article

Dupilumab for refractory chronic rhinosinusitis in eosinophilic granulomatosis with polyangiitis.

Published in:

Rheumatology, 2025, v. 64, n. 5, p. 2892, doi. 10.1093/rheumatology/keae554

By:

Padoan, Roberto;
Davanzo, Federica;
Iorio, Luca;
Saccardo, Tommaso;
Roccuzzo, Giuseppe;
Zampollo, Sonny;
Nicolai, Piero;
Doria, Andrea;
Ottaviano, Giancarlo

Publication type:

Article

Laboratory-confirmed respiratory syncytial virus (RSV) hospitalizations: a national all ages cross-section evaluation, 2020–2024.

Published in:

Israel Journal of Health Policy Research, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s13584-025-00693-5

By:

Glatman-Freedman, Aharona;
Gur-Arie, Lea;
Dichtiar, Rita;
Keinan-Boker, Lital;
Bromberg, Michal

Publication type:

Article

The Immunomodulatory Role of Galectin-1 in the Tumour Microenvironment and Strategies for Therapeutic Applications.

Published in:

Cancers, 2025, v. 17, n. 11, p. 1888, doi. 10.3390/cancers17111888

By:

Griffiths, Alice;
Udomjarumanee, Palita;
Georgescu, Andrei-Stefan;
Barri, Muruj;
Zinovkin, Dmitry A.;
Pranjol, Md Zahidul I.

Publication type:

Article